BACKGROUND: England has invested in chlamydia screening interventions for young people. It is not known whether young people in poorer socioeconomic circumstances (SEC) are at greater risk of chlamydia and therefore in greater need of screening. OBJECTIVE: To conduct a systematic review examining socioeconomic variations in chlamydia prevalence or positivity in young people. DATA SOURCES: Eight bibliographic databases using terms related to chlamydia and SEC, supplemented by website and reference searches. ELIGIBILITY: Studies published 1999-2011 in North America, Western Europe, Australia or New Zealand, including populations aged 15-24 years, with chlamydia prevalence or positivity diagnosed by nucleic acid amplification testing. APPRAISAL AND SYNTHESIS: Two reviewers independently screened references, extracted data, appraised studies meeting inclusion criteria and rated studies as high, medium or low according to their quality and relevance. Socioeconomic variations in chlamydia were synthesised for medium/high-rated studies only. RESULTS: No high-rated studies were identified. Eight medium-rated studies reported variations in chlamydia prevalence by SEC. In 6/8 studies, prevalence was higher in people of poorer SEC. Associations were more often significant when measured by education than when using other indicators. All studies measuring positivity were rated low. Across all studies, methodological limitations in SEC measurement were identified. CONCLUSIONS: The current literature is limited in its capacity to describe associations between SEC and chlamydia risk. The choice of SEC measure may explain why some studies find higher chlamydia prevalence in young people in disadvantaged circumstances while others do not. Studies using appropriate SEC indicators (eg, education) are needed to inform decisions about targeting chlamydia screening.
BACKGROUND: England has invested in chlamydia screening interventions for young people. It is not known whether young people in poorer socioeconomic circumstances (SEC) are at greater risk of chlamydia and therefore in greater need of screening. OBJECTIVE: To conduct a systematic review examining socioeconomic variations in chlamydia prevalence or positivity in young people. DATA SOURCES: Eight bibliographic databases using terms related to chlamydia and SEC, supplemented by website and reference searches. ELIGIBILITY: Studies published 1999-2011 in North America, Western Europe, Australia or New Zealand, including populations aged 15-24 years, with chlamydia prevalence or positivity diagnosed by nucleic acid amplification testing. APPRAISAL AND SYNTHESIS: Two reviewers independently screened references, extracted data, appraised studies meeting inclusion criteria and rated studies as high, medium or low according to their quality and relevance. Socioeconomic variations in chlamydia were synthesised for medium/high-rated studies only. RESULTS: No high-rated studies were identified. Eight medium-rated studies reported variations in chlamydia prevalence by SEC. In 6/8 studies, prevalence was higher in people of poorer SEC. Associations were more often significant when measured by education than when using other indicators. All studies measuring positivity were rated low. Across all studies, methodological limitations in SEC measurement were identified. CONCLUSIONS: The current literature is limited in its capacity to describe associations between SEC and chlamydia risk. The choice of SEC measure may explain why some studies find higher chlamydia prevalence in young people in disadvantaged circumstances while others do not. Studies using appropriate SEC indicators (eg, education) are needed to inform decisions about targeting chlamydia screening.
Authors: Saurabh Dixit; Shree R Singh; Abebayehu N Yilma; Ronald D Agee; Murtada Taha; Vida A Dennis Journal: Nanomedicine Date: 2014-03-04 Impact factor: 5.307
Authors: Clare Tanton; Lorraine McDonagh; Melissa Cabecinha; Soazig Clifton; Rebecca Geary; Greta Rait; John Saunders; Jackie Cassell; Chris Bonell; Kirstin R Mitchell; Catherine H Mercer Journal: BMC Public Health Date: 2021-02-26 Impact factor: 4.135
Authors: Joanna Crichton; Matthew Hickman; Rona Campbell; Harriet Batista-Ferrer; John Macleod Journal: BMC Public Health Date: 2015-07-30 Impact factor: 3.295
Authors: Sarah C Woodhall; Kate Soldan; Pam Sonnenberg; Catherine H Mercer; Soazig Clifton; Pamela Saunders; Filomeno da Silva; Sarah Alexander; Kaye Wellings; Clare Tanton; Nigel Field; Andrew J Copas; Catherine A Ison; Anne M Johnson Journal: Sex Transm Infect Date: 2015-08-19 Impact factor: 3.519
Authors: Caroline Free; Ona L McCarthy; Melissa J Palmer; Rosemary Knight; Phil Edwards; Rebecca French; Paula Baraitser; Ford Colin Ian Hickson; Kaye Wellings; Ian Roberts; Julia V Bailey; Graham Hart; Susan Michie; Tim Clayton; George B Ploubidis; James R Carpenter; Katy M E Turner; Karen Devries; Kimberley Potter Journal: BMJ Open Date: 2020-03-08 Impact factor: 2.692
Authors: Pam Sonnenberg; Soazig Clifton; Simon Beddows; Nigel Field; Kate Soldan; Clare Tanton; Catherine H Mercer; Filomeno Coelho da Silva; Sarah Alexander; Andrew J Copas; Andrew Phelps; Bob Erens; Philip Prah; Wendy Macdowall; Kaye Wellings; Catherine A Ison; Anne M Johnson Journal: Lancet Date: 2013-11-26 Impact factor: 79.321